论文部分内容阅读
目的:探讨食管癌病人术后EEN应用的可行性和获益性。方法:通过对288例食管癌病人术后实施EEN(EN组)和288例行PN(对照组)的对照研究,分析两种不同方式营养支持对病人主要生化指标、机体营养状况、肠道功能恢复及并发症治疗情况的影响。结果:EN组EN支持1周后,血清ALB升高显著,与对照组比差异有显著性意义(P<0.05)。肠道功能恢复提前,对术后出现的胃排空障碍、吻合口瘘等并发症的治疗,EN组有明显优势。结论:食管癌病人术后EEN可行、安全、有效,对病人术后体力恢复、预防和治疗术后并发症有较好的作用。
Objective: To investigate the feasibility and benefit of postoperative EEN in esophageal cancer patients. Methods: 288 cases of esophageal cancer patients after the implementation of EEN (EN group) and 288 cases of PN (control group) control study, analysis of two different ways of nutritional support for patients with major biochemical indicators, body nutrition, intestinal function Recovery and complications of the impact of treatment. Results: Serum ALB increased significantly after EN support for EN group, which was significantly different from that of control group (P <0.05). Intestinal function recovery in advance, postoperative gastric emptying disorders, anastomotic leakage and other complications of treatment, EN group has obvious advantages. Conclusion: The postoperative EEN of patients with esophageal cancer is feasible, safe and effective. It has a good effect on postoperative physical recovery, prevention and treatment of postoperative complications.